These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 3301658)

  • 1. Current concepts in the management of thalassemia.
    Festa RS
    Indian J Pediatr; 1987; 54(3):379-89. PubMed ID: 3301658
    [No Abstract]   [Full Text] [Related]  

  • 2. Modern management of thalassemia.
    Festa RS
    Pediatr Ann; 1985 Sep; 14(9):597-600, 602-3, 606. PubMed ID: 3903631
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical management of beta-thalassemia.
    Graziano J; Piomelli S
    Tex Rep Biol Med; 1980-1981; 40():355-64. PubMed ID: 7034276
    [No Abstract]   [Full Text] [Related]  

  • 4. Total management of thalassaemia major.
    Modell B
    Arch Dis Child; 1977 Jun; 52(6):489-500. PubMed ID: 879834
    [No Abstract]   [Full Text] [Related]  

  • 5. Chelation therapy, transfusion requirement, and iron balance in young thalassemic patients.
    Piomelli S; Graziano J; Karpatkin M; Dudell GG; Hart D; Hilgartner M; Khanna K; Valdes-Cruz LM; Vora S
    Ann N Y Acad Sci; 1980; 344():409-17. PubMed ID: 6930881
    [No Abstract]   [Full Text] [Related]  

  • 6. Ascorbic acid enhancement of desferrioxamine-induced urinary iron excretion in thalassemia major.
    O'Brien RT
    Ann N Y Acad Sci; 1974; 232(0):221-5. PubMed ID: 4528431
    [No Abstract]   [Full Text] [Related]  

  • 7. Desferrioxamine-induced iron outputs in Cooley's anemia. Results and perspectives.
    Cantore N; Tortarolo M; Volpe E; Gonnella F; Valente A; Buonanno G
    Haematologica; 1981 Apr; 66(2):196-207. PubMed ID: 6791996
    [No Abstract]   [Full Text] [Related]  

  • 8. [Therapy of thalassemias].
    Bender-Götze C
    Monatsschr Kinderheilkd (1902); 1979 Dec; 127(12):714-5. PubMed ID: 514281
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical management of thalassemia. Decreasing iron stores during intensive chelation therapy.
    Cohen A; Schwartz E
    Ann N Y Acad Sci; 1980; 344():405-8. PubMed ID: 6930880
    [No Abstract]   [Full Text] [Related]  

  • 10. [Our experience with "supertransfusive" treatment of homozygous beta-thalassemia].
    Esposito L; Ferrara M; Ponte G
    Pediatria (Napoli); 1983; 91(1):27-30. PubMed ID: 6889088
    [No Abstract]   [Full Text] [Related]  

  • 11. [Remarks on the treatment of thalassemia major].
    Brüster H
    Kinderarztl Prax; 1965 Aug; 33(8):337-40. PubMed ID: 5840820
    [No Abstract]   [Full Text] [Related]  

  • 12. The management of the improved prognosis in thalassemia major.
    Modell B
    Birth Defects Orig Artic Ser; 1982; 18(7):329-37. PubMed ID: 6819016
    [No Abstract]   [Full Text] [Related]  

  • 13. Desferrioxamine and ascorbic acid supplement in E-B thalassaemia.
    Dutta AK; Ray R; Chandra S; Bhattacharya DK
    J Assoc Physicians India; 1988 Jul; 36(7):463-4. PubMed ID: 3204100
    [No Abstract]   [Full Text] [Related]  

  • 14. Management of thalassaemia major.
    Modell B; Petrou M
    Arch Dis Child; 1983 Dec; 58(12):1026-30. PubMed ID: 6660889
    [No Abstract]   [Full Text] [Related]  

  • 15. Oral ascorbic acid and iron excretion in thalassemic children treated with desferrioxamine-methansulfonate (Desferal).
    Hathirat P; Isarangkura P; Areekul S; Pleehachinda R; Tuntawiroon M
    Birth Defects Orig Artic Ser; 1988; 23(5B):129-33. PubMed ID: 3390535
    [No Abstract]   [Full Text] [Related]  

  • 16. Long-term desferrioxamine therapy in thalassemia.
    Modell CB; Beck J
    Ann N Y Acad Sci; 1974; 232(0):201-10. PubMed ID: 4528634
    [No Abstract]   [Full Text] [Related]  

  • 17. Cooley anemia: high transfusion regimen and chelation therapy, results, and perspective.
    Weiner M; Karpatkin M; Hart D; Seaman C; Vora SK; Henry WL; Piomelli S
    J Pediatr; 1978 Apr; 92(4):653-8. PubMed ID: 633033
    [No Abstract]   [Full Text] [Related]  

  • 18. Long-term effect of splenectomy on transfusion requirements in thalassemia major.
    Cohen A; Gayer R; Mizanin J
    Am J Hematol; 1989 Apr; 30(4):254-6. PubMed ID: 2929586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduction of iron overload in thalassemia.
    Piomelli S; Graziano J
    Birth Defects Orig Artic Ser; 1982; 18(7):339-46. PubMed ID: 7159742
    [No Abstract]   [Full Text] [Related]  

  • 20. The management of thalassemia major.
    Pearson HA; O'Brien RT
    Semin Hematol; 1975 Jul; 12(3):255-65. PubMed ID: 1079633
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.